Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netarsudil Nocturnal and Diurnal IOP Study
NCT02874846Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Jul 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of netarsudil in ocular hypertension, open-angle glaucoma (OAG), sponsored by Aerie Pharmaceuticals. Started Jul 2016; status: completed.
02
Drugs
netarsudil
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT02874846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874846.